1009PDThe identification of the AXL/Gas6 signalling axis as a key player of myelodysplastic syndrome (MDS) and the potential of the oral selective AXL inhibitor bemcentinib in the treatment of MDS

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; no. suppl_8
Main Authors Medyouf, H, Tirado-Gonzalez, I, Mies, A, Nevmerzhitskaya, A, Kubasch, A-S, Platzbecker, U
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy286.005